Pseudotumor cerebri as an important differential diagnosis of papilledema in children

Related Experiment Video

Updated: Aug 14, 2026

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Felix Distelmaier1, Ulrike Sengler, Martina Messing-Juenger

  • 1Department of General Pediatrics, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany. distelmaier@med.uni-duesseldorf.de

Brain & Development
|December 22, 2005
PubMed

Insights

Childhood pseudotumor cerebri (PTC) requires careful management to prevent vision loss. Acetazolamide is effective, but younger children may need different treatments, including surgery if medical options fail.

Area of Science:

  • Pediatric Neurology
  • Ophthalmology

Background:

  • Primary pseudotumor cerebri (PTC) is a rare condition in children characterized by elevated cerebrospinal fluid (CSF) pressure.
  • It can lead to serious visual complications if not managed promptly.

Purpose of the Study:

  • To investigate the clinical features of pediatric PTC.
  • To highlight treatment options for normalizing intracranial pressure in children with PTC.

Main Methods:

  • Retrospective chart review of 12 pediatric patients diagnosed with primary PTC.
  • Analysis of clinical presentations, diagnostic findings, and treatment outcomes.

Main Results:

  • Headache was the most common presenting symptom; four patients were asymptomatic.
  • Acetazolamide was the primary treatment, with furosemide and prednisone as second-line options.
  • Younger children were more difficult to treat, and one required surgical intervention (ventricular-peritoneal shunting).

Conclusions:

  • Treatment aims to relieve symptoms and preserve vision.
  • Acetazolamide is an effective first-line therapy for reducing intracranial pressure.
  • Younger children may present unique challenges in PTC management, potentially indicating age-related etiological differences, and surgical intervention should be considered for refractory cases.
Abstract

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...